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ABSTRACT
EFFECTS OF mlc GENE MODULATION ON ACETATE ACCUMULATION IN
ESCHERICHIA COLI CULTURE
by Melvin F. Chen
When Escherichia coli (E. coli) is grown in the presence of excess glucose,
acetate is produced, oftentimes as an undesired by-product. Mlc is a global repressor for
sugar transporters in E. coli, including glucose. This body of work examines the
overexpression of Mlc via expression vectors in E. coli cultures under constitutive and
inducible promoters. Sequence changes to the translational start codon and codon 52 of
the mlc sequence inserted in the expression vectors were introduced. These changes were
evaluated for their impact on glucose uptake rates, acetate production, and overall cell
growth when Mlc was overexpressed in E. coli cultures in the presence of excess glucose.
Furthermore, expression vectors carrying the mlc gene versions were co-transformed with
a plasmid encoding for a therapeutic protein in order to study the impact of Mlc
overexpression on the production of the therapeutic protein. Results showed varied
levels of Mlc overexpression; however a correlation was drawn between increased Mlc
expression and decreased acetate production as a result of slower glucose uptake into the
cell. This characteristic resulted in improved cell growth in the form of higher density
cultures. In addition to growing to higher cell densities, a 1.7-fold increase of therapeutic
protein production was observed in cultures overexpressing Mlc, compared to the control.
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CHAPTER ONE: INTRODUCTION
Cohen et al. showed in 1973 that it is possible to successfully transform
biologically functional recombinant plasmids into Escherichia coli (E. coli). This event
initiated the field of biotechnology [1] and E. coli will be forever linked to the birth of
biotechnology. In 1978, scientists at Genentech, Inc. and the City of Hope National
Medical Center successfully synthesized human insulin utilizing recombinant DNA
technology and the machinery of E. coli. In 1982 the Food and Drug Administration
(FDA) approved for the first time a recombinant protein (human insulin) to be used as a
therapeutic [2] and through 2008 there have been 151 FDA and/or European Medicines
Agency (EMEA) approved recombinant therapeutics produced from bacterial or yeast
cells [3, 4]. E. coli is a gram-negative, rod-shaped bacterium that has been utilized in
industry because of its “ease of manipulation,” “long history in laboratory cultures,” and
known genome [5]. E. coli cultures have been shown to achieve high volumetric
recombinant protein productivities at high cell densities and a major effort has been made
in industry to improve production cell densities to maximize product yield [6].
1.1

Glucose Metabolism in E. coli cultures
The general assumption is that E. coli cells will continue to grow as long the

nutrients required for growth are present. One major requirement for cell growth is a
carbon source and oftentimes glucose is provided to fill this need [6]. To maximize cell
growth and density, glucose is often provided in excess; the consequence, however, is the
formation of acetate. It has been suggested that acetate production is the result of an
imbalance between glucose metabolism and respiration [7]. Within E. coli, glucose is

metabolized through glycolysis and one of the products from this process, pyruvate, is
oxidized and shuttled into the tricarboxylic acid cycle (TCA) also known as the citric acid
cycle. The latter stage is cellular respiration and it is an imbalance between this and
glycolysis that leads to excess acetate formation, as depicted below in Figure 1. Under
aerobic conditions acetate is formed as a byproduct of pyruvate and acetyl CoA
metabolism [8]. A major contributor of acetate formation is the metabolism of acetylCoA through the Pta-Ack pathway, which becomes activated from overloading the TCA
cycle [10]. The Pta-Ack pathway is responsible for the catabolism and anabolism of
acetate. E. coli, however, will metabolize glucose solely as its carbon source if it is
present; therefore, acetate continues to accumulate, as a result of glucose-rich media.

Figure 1. Acetate is formed as a result of glucose metabolism in E. coli culture [8].
Overloading the TCA cycle can lead to acetate accumulation.
The products from the TCA cycle are then passed to the membrane bound
electron transport chain (ETC) where ATP is produced. Under aerobic conditions,
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oxygen serves as an electron acceptor at the end of the ETC. E. coli is metabolically
versatile and can sustain growth under anaerobic conditions. The absence of oxygen
results in the reduced utilization of the TCA cycle leading to the incomplete oxidation of
glucose or other sugars. As a result, acetate is formed as the primary byproduct [9].
1.2

The Acetate Problem
The accumulation of acetate within E. coli has a toxic effect and has been studied

for decades dating back to the early 1980s [6]. Within the cell, acetate can be found in
two forms, as an anion salt (CH3COO-) and as a protonated form (CH3COOH) depending
on pH; these are diagrammed below in Figure 2. It is generally understood that acetate is
produced in its protonated acidic form under aerobic conditions in a medium of relatively
neutral pH [11]. As a result, acetate lowers the pH of the culture thereby creating an
unfavorable environment for the cells to grow. It has been shown to have the greatest
negative effects at concentrations greater than 2 g/L [6]. Studies have shown a direct
impact of acetate accumulation on recombinant protein production as well as a reduction
in cellular growth rate, biomass yield, and cell densities [10].

Figure 2. The ion and protonated form of acetate (from left to right). Both forms are
found at neutral pH [5].
As a result, several efforts have been made to eliminate or minimize the effect
acetate has on fermentation cultures including the use of fed-batch cultures to control the
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level of glucose uptake, two-stage cultures, in situ removal of acetate, and buffered media
to control the pH of the culture. Each has resulted in limited or minimal success [11].
1.3

Background

1.3.1

Transport of sugar across cell membrane
For glucose and other sugars to be utilized by E. coli, they must be transported

from the medium across the cell membrane into the cell where it undergoes glycolysis.
The mechanism responsible for the transport of sugar utilizes a complex network of
enzymes and proteins known as the phosphotransferase system (PTS). There is a specific
PTS responsible for the transport of glucose; however, there are others responsible for
transporting other sugars that also have the capability of transporting glucose. The role
of the PTS, as the name suggests, is to transfer a phosphate group from
phosphoenolpyruvate (PEP) to a sugar. In the glucose specific PTS, the phosphate group
is passed from PEP to Enzyme I (EI) to histidine protein (HPr) to Enzyme IIA (EIIAGlc)
to the inner membrane bound Enzyme IIB and integral membrane protein Enzyme IIC
(referred to jointly as EIICBGlc) and lastly to glucose upon transfer across the cell
membrane forming glucose-6-phospate (G6P), the first step of glycolysis [12]. This is
illustrated in Figure 3. This initial step in glycolysis prevents glucose from escaping
from the cell back into the medium.
Enzymes EI and HPr are generic transporters, while EIIAGlc and EIICBGlc are
specific to the transport of glucose. Each is encoded by the ptsI, ptsH, crr, and ptsG
gene, respectively where ptsI, ptsH and crr are a part of the pts operon and ptsG is part of
the ptsG operon. An operon describes the collection of genes (called structural genes)
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generally under the control of a single promoter (which initiates transcription).
Additionally, this group of genes may be under the control of an operator, a region of
DNA in which a repressor may bind to negatively regulate transcription.

Figure 3. The phosphotransferase system (PTS) transfers glucose from outside the cell
across the cell membrane into the cytoplasm by process of transferring a phosphate group
originating from phosphoenolpyruvate (PEP) [12].
1.3.2

Gene Regulation and Expression
The regulation of transcription generally occurs in regions just upstream of the

transcriptional start site [13]. These regions are called the promoter and the operator.
The promoter is the sequence of DNA recognized and bound by RNA polymerase (the
enzyme responsible for transcription). Some promoters are always “on,” also known as
constitutively active, meaning RNA polymerase is always able to bind, and transcription
can continuously occur. There are also instances of positive and negative regulation,
where promoters need to be turned on or can be turned off with an inducer or repressor.
There are proteins that recognize and bind to the operator region, leading to a
conformational change, which alters the interaction between RNA polymerase and
promoter. Figure 4 illustrates the relationship of the promoter and operator in relation to
the transcribed region of a gene.
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Figure 4. A generalized illustration of the regions of a gene responsible for regulation
and expression. The transcriptional start site is referred to position +1; all other sites are
given in relation to this site [13].
1.3.3

Positive Regulation by CRP-cAMP
An example of positive regulation is the CRP-cAMP complex [13]. Cyclic

adenosine monophosphate (cAMP) binds to the cAMP repressor protein (CRP) forming a
CRP-cAMP complex that is able to bind a specific site in DNA (neither protein is able to
bind DNA by itself). The bound complex leads to a conformational change in the DNA,
which then allows for RNA polymerase to bind and transcribe the downstream genes.
The expression of the pts and ptsG operons are both regulated by this complex.
1.4

Discovery of the mlc gene
In 1995, Hosono et al. created a gene library to identify genes that would

overcome acetate inhibition [10]. They created a mixture of plasmids by ligating
expression vector pUC19 (digested with BamHI) with segments of chromosomal E. coli
DNA. A wild-type strain of E. coli was transformed with the resulting plasmid mixture.
The transformants were then plated on agar plates and the resultant colonies were
observed. Most were small; however, one was much larger. It was postulated that the
larger colony was the direct result of the acquired ability to overcome the toxic effects of
acetate. The plasmid DNA from that colony was isolated and through a DNA deletion
technique, the DNA sequence responsible for forming the larger colony was isolated.
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This gene was named mlc short for “making large colonies” (convention states that when
using all lower case, italicized letters, mlc refers to the gene, whereas capitalizing the first
character, [e.g. Mlc] describes to the protein). These steps are illustrated below in Figure
5. Subsequent studies have shown that the introduction of an Mlc expressing plasmid in
to E. coli can overcome the inhibitory effects of acetate [14].

Figure 5. The mlc gene was discovered be transforming recombinant plasmids into E. coli
and identifying those plasmids that allowed for the growth of large colonies [10].
Mlc is a 44.5 kDA protein that has been shown to be a transcriptional regulator,
which controls glucose uptake in E. coli by repressing the expression of genes associated
with the phosphotransferase system (PTS) and transport of glucose across the cell
membrane. Overexpression of Mlc slows the uptake of glucose into the cell significantly,
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such that acetate is formed as a by-product of glycolysis at a rate in which E. coli can
process it before it accumulates to concentrations that inhibits cell growth [15].
It has been shown that Mlc is a global repressor for the genes encoding the
transporters of sugar within E. coli, in particular, glucose [14]. By limiting the uptake of
glucose within the cell, Mlc impacts the glycolytic pathway and TCA cycle. Reducing
the rate at which glucose is introduced into the cell also lowers the rate at which pyruvate
is produced through glycolysis. The decreased rate of pyruvate generation reduces the
burden on the TCA cycle and allows for more pyruvate to be metabolized through the
TCA cycle rather than through the Pta-Ack pathway, thus reducing the formation of
acetate.
1.5

Significance
Overcoming acetate accumulation while continuing to grow in the presence of

excess glucose could allow for E. coli cultures to achieve higher cell growth rates and
fully utilize their carbon source. With recombinant protein production, higher growth
rates and longer culture runs could lead to increased product yields. Limiting the rate of
glucose uptake by overexpressing Mlc may reduce acetate production such that there is
no accumulation or it is reduced significantly, minimizing any toxic effects.
This project studied the overexpression of Mlc and its effect on cell density and
recombinant protein production. Modulations to the mlc gene and its expression were
incorporated based on results reported in the literature where several sequence changes
improved the expression of Mlc. These included sequence variations to the mlc gene,
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induced and constitutive expression, and use of E. coli host strains of with different
genotypes.
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CHAPTER TWO: LITERATURE REVIEW
2.1

Discovery of the mlc gene
In 1995, Hosono et al. attempted to identify the gene(s) that were linked to the

inhibition of E. coli growth in glucose-rich media caused by the accumulation of acetate
[10]. A ligation mixture of the plasmid pUC19 digested with BamH1 and chromosome
fragments from wild-type E. coli strain W3110 partially digested with SauAI was
transformed into the streptomycin resistant E. coli strain JM103. From the resulting
transformants, one colony (out of 3,000) grew noticeably larger than the others. The
DNA inserted into the plasmid was shortened until the gene that gave the host strain the
ability to grow larger colonies was isolated. This work is illustrated in Figure 3. Because
this gene was speculated as being responsible for making large colonies, it was named
after the acronym: mlc. The nucleotide sequence that was identified as the gene mlc is
depicted in Figure 6.
The researchers continued to study the growth of E. coli with the mlc containing
plasmid compared to the wild-type strain [10]. In the presence of glucose, the wild-type
strain accumulated acetate, which lowered the pH and caused growth to stop. This
occurred prior to the exhaustion of the glucose supply. A similar culture was grown
using a sodium phosphate buffer (pH 7.2) to help control the pH. In this case, acetate
was produced and initially accumulated in culture, however once the glucose was fully
metabolized the acetate was depleted from the media as well, supporting the theory that
the drop in pH due to acetate accumulation renders a toxic effect. A culture of the mutant
strain consumed glucose at a slower rate compared to the aforementioned wild-type
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cultures (regardless of buffered media), however nearly half the amount of acetate was
accumulated and similar to the buffered cultures, they continued to grow until both
glucose and acetate were completely consumed.

Figure 6. The nucleotide sequence for mlc gene was shown to be responsible for
overcoming acetate inhibition in glucose-rich media. The boxed region starting at 110 bp
indicates the CRP-cAMP binding site responsible for positive regulation. The amino
acids associated with the codons in the coding region of the gene are listed below in
sequence (in single character abbreviations) [10].

11

Lastly, Hosono et al. (1995) showed that the Mlc protein was a sequence homolog
to NagC, a protein involved in the uptake and metabolism of N-acetylglucosamine (a
glucose derivative) [10]. Amino acid sequence comparison showed 40.0% identity and
81.3% similarity between the two proteins.
2.2

The function of Mlc as a repressor
Due to its high homology to NagC, Mlc was studied with regards to its role in

sugar transport within E. coli. In 1998, Plumbridge and Decker et al. showed that Mlc
affected the manXYZ operon and maltose regulon, respectively [16, 17]. Each encodes
for transporters responsible for bringing specific sugars into the cell. The manXYZ
operon is responsible for several sugars including glucose and mannose. The maltose
regulon consists of four operons that produce the transporters for maltose and
maltodextrins and is regulated by a single regulator protein, MalT [18]. Using DNase
footprinting, a technique that identifies DNA-protein interactions with radioactively
labeled DNA templates and DNase (an enzyme that randomly cleaves DNA), regions of
DNA that Mlc bind could be identified.
In the case of the manXYZ operon, Mlc was found to bind to two binding sites for
the repressor NagC. Mlc in fact, was shown to bind more tightly to NagC operators than
NagC itself. Plumbridge [16] conducted two similar sets of experiments on NagC and
Mlc to study their impact on the manXYZ operon. Each repressor gene was knocked out
and overexpressed (in separate experiments) and the expression of the first gene of the
operon, manX, was observed. For NagC, the null mutation resulted in minimal effects
whereas the Mlc null yielded a three-fold increase in manX expression. Overexpression
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of NagC led to an eight-fold decrease in manX. Similarly, overexpression of Mlc through
a plasmid utilizing the endogenous Mlc promoter reduced expression by 10-fold.
Another experiment performed by Plumbridge [16] overexpressed Mlc using the lac
promoter and yielded greater than 100-fold decrease in manX expression.
The effect of Mlc on the maltose regulon is different, but yields similar results.
The regulon is under the positive control of a single transcriptional activator, MalT [18].
Experiments show that Mlc does not bind directly to regions of the maltose regulon but
rather binds to the regulating region of malT, thus repressing the expression of the
positive activator. The expression of Mlc from a multicopy plasmid reduced the
expression of MalT, while the null mutation of Mlc led to a three-fold increase in
expression. Additionally, using the same DNase footprinting technique, Decker et al.
(1998) showed that Mlc binds to its own regulating region, thus repressing its own
expression [17]. Having been shown to repress the expression of various sugar
transporters, suggests that Mlc may regulate other operons as well and may be a global
regulator of carbohydrate metabolism.
Later in 1998, Plumbridge and Kimata et al. [14, 19] conducted separate studies
in which they each linked Mlc to the repression of a gene that is part of the
phosphotransferase system (PTS). That gene, ptsG, encodes one component (EIICBGlc)
of the two part glucose-specific transporter EIIGlc. They showed that Mlc binds to two
different sites in the ptsG promoter region, which inhibits the transcription of ptsG by
prohibiting the binding of RNA polymerase. Kimata et al. (1998) showed that although
Mlc affects the transport of glucose and other sugars, the sugars did not directly affect
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Mlc activity [14]. Figure 7 shows a gel mobility shift assay, where several sugars were
run with Mlc and DNA fragments containing the ptsG promoter. The results show that
glucose, mannose and xylose did not affect the binding of Mlc to the ptsG promoter.
sugar
mlc

-

+

Glc
+

Man
+

Xyl
+

1

2

3

4

5

Mlc-DNA complex!
free DNA!

Figure 7. A gel mobility assay show that the presence of sugar (Glc = glucose, Man =
mannose, Xyl = xylose) does not affect the activity of Mlc. “+” denotes the presence of
while “-” denotes the absence. Adapted with permission from ref. [14] © 1998
Molecular Microbiology.
Several studies were conducted to further investigate the effect Mlc has on the
PTS, specifically its role in regulating ptsHI, the operon that codes for two PTS proteins,
enzyme I (EI) and HPr. Each is a soluble protein that functions to transfer phosphate
groups to membrane-bound sugar transporters such as the glucose transporter EIIGlc [2022]. PtsHI has been shown to be under the control of two promoters, P0 and P1 [23].
Examination of the mRNA through S1 analysis showed that Mlc enhances expression
from the P0 promoter, however only a negligible difference in expression is observed
with the P1 promoter. Additionally, similar to the previous findings, the researchers
found that Mlc represses the ptsHI operon, while glucose induces its expression. It was
shown that a mutation in the mlc gene led a four-fold increase in ptsH expression, while
the presence of mlc on a multicopy plasmid repressed expression by three-fold. Thus it
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was concluded that Mlc negatively regulates the pts operon. The regulation of the pts
operon is depicted in Figure 8.

Figure 8. The pts operon consists of three genes: ptsH, ptsI and crr. It is positively and
negatively regulated by CRP-cAMP and Mlc, respectively at the P0 promoter site.
Reprinted with permission from ref. [23] © 2001 EMBO Journal [23].
It has been shown through repeated experiments that Mlc represses several PTS
associated operons and that in wild-type cells, glucose relieves the Mlc-mediated
repression and induces the expression of the targeted genes. The mechanism, however,
by which glucose directly or indirectly modulates Mlc activity had not yet been
determined. In 2000, Tanaka et al. showed that an interaction exists between nonphosphorylated EIIGlc and Mlc [23]. Without a glucose source present, EIIGlc is in the
phosphorylated form and does not bind Mlc. As a result, the repressor freely moves
throughout the cytoplasm regulating the transcription of the pts operon. In the presence
of glucose, EIIGlc is generally found in the dephosphorylated state because of PEPdependent phosphorylation of glucose. In the phosphorylated form, Tanaka et al. (2000)
showed EIIGlc sequesters Mlc to the membrane, physically removing Mlc from DNA
access in the cytoplasm thereby removing the repressor and inducing transcription of the

15

pts operon. Figure 9 depicts the proposed model of EIIGlc-Mlc interaction in the presence
and absence of glucose. Nam et al. (2001) later confirmed these findings [24].

Figure 9. The membrane bound component of the glucose transporter, IICBGlc sequesters
Mlc when it is in the dephosphorylated state limiting the Mlc available to repress the
expression of pts related operons. Senarios A and B depicts the situations where glucose
is absent and present, respectively. In the absence of glucose, IICBGlc is phosphorylated
and is unable to bind Mlc. Reprinted with permission from ref. [23] © 2001 EMBO
Journal [23].
2.3

Modulation of Mlc expression
With its function as a repressor for the pts operon better understood, Cho et al.

(2005) sought to utilize the ability for Mlc to regulate glucose metabolism within E. coli
and study how it could affect recombinant protein expression [11]. The researchers

16

created strains of E. coli that overexpressed Mlc with specific mutations in the regulatory
region of the repressor gene. Three mutations were designed, the first was a mutation in
the start codon replacing GUG with AUG; the second involved an alteration to the Mlc
binding site to prevent autoregulation; and the third mutation was an optimization of the
Shine-Dalgarno sequence and a mutation in the -10 region from CACCAT to TATAAT.
The first mutation was introduced into a host strain of E. coli, MC4100, and named
SR752. Two additional Mlc overexpressing strains were constructed, one a combination
of the first and second mutations, named SR753, and another combining all three, SR754.
The modifications to the promoter region of the Mlc gene are shown in Figure 10. Only
mutant SR754 produced enough Mlc to be detected through Western blot analysis
(including the wild-type MC4100 strain) suggesting SR752 and SR753 did not modulate
Mlc expression significantly.

Figure 10. Specific mutations were made in the regulatory region of the Mlc gene in
order to maximize the affect of Mlc on acetate accumulations. Changes from the wildtype MC4100 strain are shown in lowercase red letters. Adapted with permission from
ref. [11] © 2005 Journal of Biotechnology.
The effect of Mlc overexpression on cell growth was compared between SR754
and wild-type MC4100 in the presence glucose. It was shown that although higher initial
specific growth rates were observed with MC4100, SR7554 continued to grow after
MC4100 had entered the stationary phase. The measured specific growth rates of
MC4100 and SR754 at various concentrations are shown in Table 1. These data shows
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that the growth rate of the SR754 mutant is not as significantly impacted by an increase
in available glucose as is the wild-type strain. Additionally, it was observed that there
was a continuous accumulation of acetate in the MC4100 culture through the 15 hours of
measured growth, whereas the SR754 culture initially saw a rise in acetate concentration
in the first six hours followed by a steady decrease. A comparison of MC4100 and
SR754 cell growth as well as glucose consumption and acetate production are displayed
in Figures 11 and 12, respectively.
Table 1. A comparison of specific growth rates between MC4100 (wild-type) and SR754
(mutated Mlc regulatory region) at varying glucose concentrations. Adapted with
permission from ref. [11] © 2005 Journal of Biotechnology.
Glucose
concentration
(%)
0.0
0.1
0.3
0.5

Specific growth rate [h-1]
MC4100

SR754

0.54
0.84
1.20
1.31

0.55
0.74
0.75
0.82
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Figure 11. Approximate growth profiles based on data from Cho et al. of wild-type
MC4100 and mutant SR754 strains were compared. Although SR754 growth initially
lagged behind MC4100, it continued to be productive long after MC4100 reached its
stationary phase. Adapted with permission from ref. [11] © 2005 Journal of
Biotechnology.

Figure 12. Comparison of approximate glucose consumption and acetate accumulation
between wild-type MC4100 and mutant SR754 based on data collected by Hosono et al.
While glucose is consumed more rapidly in MC4100, acetate continues to accumulate
throughout the culture, whereas with SR754, a slower rate of consumption of glucose
leads to a plateau in acetate accumulation. Adapted with permission from ref. [11] ©
2005 Journal of Biotechnology.
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Both MC4100 and SR754 were transformed with plasmid, pGAL and pGFPuv
separately. The first encodes for the ß-galactosidase gene and the latter for the green
fluorescent protein. Studies showed that under similar growth conditions with 0.3%
glucose, SR754 produced four times more ß-galactosidase activity and 10 times greater
fluorescence as compared to MC4100. This suggests that the reduced acetate
accumulation may lead to better recombinant protein production in addition to prolonged
cell growth.
Later in 2005, Gerber et al. isolated and identified a point mutation in the mlc
gene, R52H, while expressing and purifying recombinant Mlc for crystallization and Xray analysis [15]. This discovery was accidental and they found that this point mutation
allows for higher concentrations of Mlc expression as compared to the wild-type; it was
likely selected for analysis due to the larger colonies that formed.
2.4

Summary
The protein Mlc has been found to be a global regulator of sugar transport in E.

coli. It represses the genes encoding PTS enzymes and proteins. In the example of
glucose related transport, Mlc represses both the pts and ptsG operons when glucose is
absent. In the presence of glucose, Mlc is sequestered by the PTS enzyme EIIGlc,
preventing the regulator from repressing the PTS operons. Since Mlc represses its own
expression, it was found that certain mutations within its own regulatory region lead to
increased expression. Additionally, a point mutation (R52H) within the coding region of
Mlc also leads to increased expression.
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CHAPTER THREE: OBJECTIVES
The objectives of this study were threefold. The first was to overexpress Mlc via
high and low copy expression plasmids in E. coli. The second objective was to study the
effect of the Mlc overexpression on acetate accumulation in E. coli culture, and lastly, to
examine the impact the overexpression of Mlc has on the production of a therapeutic
protein.
Unlike the gene modulation of mlc proposed by Cho et al. [2005, 11] which
included changes to the endogenous promoter and regulation regions, this series of
experiments utilized both inducible and constitutive promoters in pBR322 and
pACYC177 based expression plasmids, respectively to overexpress Mlc. Additionally,
variations in the mlc sequence that have been identified in the literature, which have been
shown to increase Mlc expression used with the inducible and constitutive systems to
determine the most effective combination.
Correlation of the overexpression of Mlc to decreased acetate accumulation and
improved therapeutic protein production may have industrial significance. The potential
to create a more robust E. coli production host that can tolerate fluctuations in the
concentration of glucose could reduce the complexity in at least one stage of recombinant
protein production. Additionally, lower concentrations of acetate accumulation may lead
to increased cell densities and subsequent protein production.
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CHAPTER FOUR: MATERIALS AND METHODS
4.1

Materials
A complete list of materials used can be found in Appendix A.

4.1.1

Expression Plasmids
Two plasmids were used to evaluate Mlc overexpression, pLMG17 and

pACYC177. These were chosen because they have been shown to be compatible with
the production plasmid that was later co-transformed to express the therapeutic protein of
interest in conjunction with Mlc. The pLMG17 plasmid was pBR322 based and included
the inducible tac promoter. The backbone of the second plasmid was pACYC177 [26,
27], which contained a constitutive promoter associated with the beta-lactamase (bla)
gene; however, additional modifications to the plasmid were also made in-house at
Genentech Inc. The plasmids confer resistance to chloramphenicol and kanamycin,
respectively. Additional properties of these plasmids can be found in Table 2.
Table 2. Properties of both expression plasmids used to study the overexpression of Mlc
in E. coli.
Plasmid
Promoter
Plasmid Size (kbp)
5' restriction site
3' restriction site
Antibiotic Resistance
Concentration of antibiotic
used for selection (ug/mL)

pACYC177
pLMG17
constitutive
inducible
3.9
2.8
KpnI
NcoI
XbaI
HindIII
Kanamycin Chloramphenicol
5.0

12.5

The expression plasmids (pLMG17 and pACYC177) were digested with the
appropriate restriction enzymes that are listed in Table 2 to generate digested vectors.
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The digested vectors were then run on a 1% agarose BioRad gel to verify digestion and
approximate product size. The product was purified using the Qiagen QIAquick Gel
Extraction kit.
4.1.2

mlc Expression Inserts
The mlc expression inserts were generated by amplifying the mlc sequence

through polymerase chain reaction (PCR) using a set of restriction site specific primers.
These primers were designed to include the DNA sequence encoding the restriction site
corresponding to the targeted expression vector as well as a short 15-20 base pair (bp)
mlc sequence. For example, the forward primer for the mlc insert to be used with the
pLMG17 expression vector begins with the sequence for the NcoI restriction site
followed by the first 15-20 bp of the mlc sequence; this is illustrated in Figure 13. A
complete list of primer sequences used can be found in Appendix B.

Figure 13. An example of a primer sequence used for mlc amplification via PCR.

The source for the DNA template used for amplification was plasmid DNA
containing the mlc sequence insert, provided by Genentech, Inc. In order to have a stock
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of this plasmid, it was transformed in to DH5α competent cells (Invitrogen) via heat
shock transformation and streaked on to an LB plate with 12.5 ug/mL chloramphenicol
(the antibiotic resistance conferred by the plasmid) and incubated overnight at 37oC.
Next a single colony from this plate was re-streaked and incubated overnight at 37oC. A
single colony from the second plate was used to inoculate 50 mL of liquid LB media and
grown overnight at 37oC in an incubated shaker. The plasmid DNA was isolated and
purified from this culture using the Qiagen QIAprep miniprep kit.
The PCR protocol used can be found in Appendix C. After amplification, the
PCR products were run on 1% agarose BioRad gels to verify amplification and
approximate product size and then purified using the Qiagen QIAquick Gel Extraction
kit. The gel-purified product was digested using the appropriate restriction enzymes.
Digestions were carried out at 37°C for two hours in New England Biolabs (NEB) buffer
2 solution. Calf intestinal alkaline phosphatase (CIP) was added for the last 30 minutes
of digestion of the expression plasmids to prevent re-ligation by removing the
phosphorylated ends of DNA. The digestion products were gel purified using the same
procedures that were used for the PCR products.
4.1.3

mlc Sequence Variants
Several mlc sequence variants were created, including changes to the start codon

sequence (from GTG to ATG), and a point mutation at codon 52 replacing an arginine
(R) to a histidine (H), also referred to a R52H. A histidine tag (a chain of six histidine
amino acids added to the end of the mlc sequence) was used in some constructs to
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perform analysis on the protein level [25]. A complete list of the sequence variants is
shown in Table 3.
Table 3. Eight mlc constructs were designed and evaluated in each of the expression
plasmids. Changes to the start codon and codon 52 were studied along with the addition
of a histidine tag.
Start Codon

GTG

ATG

Codon 52

Histidine
Tag

Arginine
Histidine
Arginine
Histidine
Arginine
Histidine
Arginine
Histidine

No
Yes
No
Yes

Alias
GTG
GTG-R52H
GTG-His
GTG-R52H-His
ATG
ATG-R52H
ATG-His
ATG-R52H-His

The change in the start codon sequence from GTG to ATG was created by
incorporating a single base pair change (from G to A) in the mlc start sequence in the
forward primer used for mlc amplification. The point mutation in codon 52 was
generated using the Stratagene QuikChange Site-Directed Mutagenesis Kit. This kit
required a pair of primers (forward and reverse) centered on the targeted codon. The
constructed primers were 51 bp in length and included a sequence change from an
arginine to histidine at codon 52. The histidine tag was added by including the sequence
for a six histidine chain to the 3’ reverse primer after the mlc sequence but before the
restriction site.
The digested and purified expression vectors and mlc inserts were ligated using a
buffered NEB T4 DNA ligase mixture. Ligation was carried out overnight at 16°C. The
ligation protocol can be found in Appendix D.
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DNA sequencing was performed in-house at Genentech to verify the sequence for
each of the mlc constructs inserted into the expression vectors.
4.1.4

Therapeutic Protein Plasmid
A Genentech, Inc. product was used to study the effect of Mlc on the production

of a therapeutic protein. The product will be referred to as Therapeutic Protein A (TPA)
and was produced using an E. coli host strain. The plasmid encoding for TPA (referred
to as pTPA) confers tetracycline resistance; 5 ug/mL of tetracycline was used throughout
the course of experiments for pTPA selectivity.
4.1.5

Host Strains
Two E. coli host strains were used throughout the course of this study, 1A2

(ΔfhuA (ΔtonA)) and16C9 (ΔfhuA phoAΔE15 Δ(argF-lac)169 deoC). Both were derived
from W3110 E. coli. 1A2 contained only a single mutation for fhuA, an undesired phage
receptor [28] and is otherwise treated as wild-type. 1A2 was used to determine baseline
wild-type expression of Mlc. The host strain 16C9 has been established as a suitable
production host for TPA [29].
4.1.6

Media
Three types of media were used throughout the shake flask portion of this study,

Luria Broth (LB), City Broth, and CRAP media. LB is a nutrient rich media that has
been used throughout industry as a standard for growing E. coli [30]. Variable amounts
of additional glucose were added to provide a better understanding of the effect the
overexpression of Mlc had on glucose uptake and acetate accumulation. City Broth is a
more robust media, containing more nutrients than LB, and was used to evaluate the
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overexpression of Mlc in higher density cultures. Lastly, CRAP media has been
established as a suitable media for the production of therapeutic proteins [31] under the
control of the phoA promoter and was used in this study to evaluate the effect the
overexpression of Mlc had on the production of TPA.
A media optimized for use in higher cell density cultures and the production of
TPA was used in the DASGIP bioreactors in order to provide the sufficient nutrients to
sustain growth and higher cell densities throughout the 36-hour fermentation runs. The
media included yeast extract, salts, peptones, MgSO4, glucose and trace elements.
4.2

Methods

4.2.1

Transformation
Transformations were carried out by heat shock treatment. After the initial

construction of the plasmids encoding Mlc was completed, DH5α cells (Invitrogen) were
used for their high transformation efficiency to generate a plasmid stock via miniprep
(Qiagen QIAprep Spin Miniprep Kit). Competent 1A2 and 16C9 cells were used for
subsequent transformations. A more detailed procedure can be found in Appendix E.
4.2.2

Shake Flask Cultures
The growth of E. coli cells transformed with plasmids encoding Mlc was studied

in shake flask cultures where a mixture of media, glucose, antibiotic, and inoculum
totaling a volume of 25 mL was added to each shake flask. Erlenmeyer flasks of 125 mL
volume were used to maintain a 1:5 volume ratio between culture and air. The
concentration of the appropriate antibiotic(s) used is listed in Table 2. Each flask was
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inoculated to an initial optical density OD550 of 0.1. Cultures were grown overnight in a
37°C shaking incubator operated at 250 RPM.
Plasmids constitutively expressing Mlc were grown in 1A2 host cells in both LB
and City Broth under varying glucose concentrations. Similarly, induced Mlc expression
was studied in 1A2 cells with City Broth. These growth conditions are listed in Table 4.
A subset of this group was co-transformed with pTPA in 16C9 host cells. Additional
experiments were conducted to study the concentration of isopropyl β-D-1thiogalactopyranoside (IPTG) required to induce a sufficient mlc response.
Table 4. Each of the eight mlc constructs was studied in pACYC177 and pLMG17 in
1A2 host cells.
Host
Strain

1A2

Plasmid/
Promoter

Media
LB
City
Broth
City
Broth

pACYC177
(constitutive)
pLMG17
(inducible)

Glucose
(g/L)
0 and 10
10
10

During the initial round of shake flask experiments, samples and measurements
were taken at approximately four, seven, and 24 hours post inoculation. This consisted of
OD550 readings and the collection of supernatant samples and 1 OD550 pellets. For
subsequent shake flask culture experiments, sampling was performed every two to four
hours for the first 16 hours, and final sample point after 24 hours.
4.2.3

Bioreactor Fermentation
The DASGIP SR1000DLS parallel bioreactor system was used as it provided a

representative environment for the production of TPA in conjunction with the
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overexpression of Mlc. The system allowed for one sided pH control; 6M NH3OH was
fed as needed based on the pH 7.3 set point. Glucose was initially batched into the
system at a concentration of 1.67 g/L and then fed based on a glucose feed algorithm. The
algorithm ultimately controlled the cultures under micro-aerobic conditions (limited
oxygen).

This algorithm was selected as it had previously been established as an

appropriate feed algorithm for the production of TPA. The reactors operated at a
temperature set point of 37°C, agitation of 1355 RPM, and an airflow rate of 60 slpm for
36 hours. Samples were taken approximately every four hours to measure OD550,
osmolality, and gross glucose concentrations. Supernatant, whole broth and 1 OD550
pellet samples were also collected for further metabolite, RNA, and protein analysis.
Four different fermentation experiments were run on the DASGIP system (two of
which were run in duplicate). Two reactors were inoculated with cultures of 16C9 cells
co-transformed with plasmids encoding for TPA and Mlc. The other two reactors were
inoculated with 16C9 cells co-transformed with pTPA and plasmid pLMG17 without the
mlc insert as control cultures for TPA expression. The reactors were inoculated with 55
mL of inoculum measuring approximately 1.5 OD550. To test the impact of Mlc on the
overfeeding of glucose in culture, a glucose excursion was executed that increased the
glucose feed rate by approximately 20% for 10 minutes once the culture had reached an
oxygen limiting state and stable glucose feed rate. The conditions for the DASGIP
fermentation runs are outlined in Table 5.
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Table 5. A total of six cultures were run using the DASGIP bioreactor system. Four
overexpressed Mlc in conjunction with TPA, while two only produced TPA.
Host
Strain

Condition
1

16C9

4.2.4

2
3
4

Transformed
Plasmids
pTPA and
pLMG17-mlc
(GTG-R52H-His)
pTPA and
pLMG17-no insert

Expressed
Protein
TPA and
Mlc
TPA

Glucose
Excursion

Run ID
JB017, JB024

X
X

JB018, JB026
JB023
JB025

RNA Preparation
RNA was isolated and purified from the 1 OD550 pellets collected from the

cultures using the Qiagen RNeasy Mini kit. RNA samples were diluted a concentration
of 10 ng/µL in RNase free water for analysis.
4.2.5

Protein Detection
Three methods were used to detect the histidine tagged Mlc protein, Western blot

with use of the Anti-His (C-term)-HRP Antibody (Invitrogen), InVision His-Tag In-Gel
Stain (Invitrogen), and the Universal His Western Blot Kit 2.0 produced by Clontech.
4.3

Instrumentation

4.3.1

Thermal Cycler
An Applied Biosystems Veriti® 96-well thermal cycler was used for the

amplification of DNA sequences through polymerase chain reaction (PCR). The PCR
protocol that was used can be found in Appendix C. The PCR products were used both
for cloning and analysis.
4.3.2

Visible (Vis) Spectrophotometer
A Thermo Scientific Genesys 20 visible spectrophotometer was used for the

quantification of cells in culture. Cells in suspension scatter light such that the more
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turbid the suspension, the greater the scattering. The spectrophotometer measures the
amount of scattering at a fixed wavelength of light (in this case λ=550) and determines
the optical density (OD550). The readings obtained at OD550 are a surrogate reading for
cell mass.
4.3.3

Ultraviolet-Visible (UV-Vis) Spectrophotometer
The quantification of nucleic acids (both DNA and RNA) was required for other

analytical steps such as real time quantitative PCR (RT-qPCR) and DNA sequencing; the
Thermo Scientific NanoDrop 2000c was used for this purpose.
4.3.4

RT-qPCR
The Agilent Stratagene Mx3005P quantitative PCR (qPCR) system was used to

detect the level of mlc RNA. The amplification of mlc RNA was performed using gene
specific primers and a 6-carboxyfluorescein (FAM) labeled probe and TaqMan One-Step
RT-PCR Master Mix Reagents produced by Applied Biosystems. Primer sequences can
be found in Appendix B. The amplification of two endogenous genes, cyaA and murA
were used as a reference in order to quantify the level of mlc RNA detected.
4.3.5

Metabolite Analysis
The Cobas Integra 400 plus (Roche Diagnostics) was used to measure

concentrations of acetate and glucose found in supernatant samples. Glucose was
quantified using Cobas Substrates Glocose HK. Acetate was quantified using acetic acid
standards from Randox Laboratories Limited. Samples were diluted 1:5 in ultrapure
water (18.2 MΩ·cm) for analysis.
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4.4

Laboratory Safety
It is of grave importance that laboratory procedures are carried out safely, and that

precautions are taken to minimize the danger from potential hazards around the work
area. There should be a clear understanding of the equipment and personnel available in
case of an accident.
4.4.5

Personal Protective Equipment
A laboratory coat, gloves and protective eyewear are required at all times while

working in the laboratory.
4.4.6

Chemical Hazards
Listed on Table 6 are the chemicals with known hazards that were used

throughout the course of these experiments and the precautions taken to minimize the risk
of injury. In the case of an accident, sinks were available on either bench top and an
eyewash and shower were located immediately outside of the laboratory. If assistance
was required, for personal injury, chemical spill, etc the Genentech Inc. security line
could be dialed for immediate response.
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Table 6. A list of chemical and their known hazards that were used throughout the course
of this study.
Chemical Compound

Health Risk/Hazard

Ethidium bromide4

mutagen, intercalates double
use of PPE
stranded DNA
toxin, respiratory tract
use within fume hood
irritant
flammable
stored within flammable cabinet

β-mercaptoethanol4
Ethanol
Guanidine
hydrochloride1,2
Acetic acid1
Sodium hydroxide1
Isopropanol1, 2
Guanidine thiocyanate2,3

Precaution

irritant

use of PPE, follow provided SOP

irritant
irritant
flammable

use of PPE, follow provided SOP
use of PPE, follow provided SOP
use of PPE, follow provided SOP

irritant

use of PPE, follow provided SOP

1

Components of buffers included in Qiagen QIAprep Miniprep kit
Components of buffers included in Qiagen QIAquick Spin kit
3
Components of buffers included in Qiagen RNeasy Plus Mini kit
4
Ethidium bromide and β-mercaptoethanol will be disposed of in dedicated waste
receptacles
2
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CHAPTER FIVE: RESULTS
Wild-type 1A2 cells were grown in overnight shake flask cultures with City Broth
and glucose concentrations varying from 0 to 20 g/L (0% to 2% w/v). An accumulation
of acetate was observed in cultures batched with 10 g/L and 20 g/L glucose. These
results can be found in Table 7 and Figures 14 and 15. Table 7 also shows a peak optical
density (OD) of 14.60 was achieved after 25 hours in the culture charged with 5 g/L
glucose. Peak ODs fell to 9.85 and 7.35 for the cultures charged with 10 and 20 g/L
glucose, respectively.
Table 7. Wild-type 1A2 cells were grown in City Broth with various glucose
concentrations. Acetate accumulation was observed in cultures batched with 10 g/L and
20 g/L glucose.

Glucose (g/L)

0
5
10
20

3
4
OD550
1.73 3.40
Acetate (mM) 8.86 7.84
Glucose (g/L) 0.00 0.00
OD550
2.11 5.86
Acetate (mM) 11.26 38.37
Glucose (g/L) 4.60 0.02
OD550
2.20 6.32
Acetate (mM) 9.99 28.81
Glucose (g/L) 7.93 4.20
OD550
1.94 4.51
Acetate (mM) 9.35 21.13
Glucose (g/L) 16.26 11.65

Time (hr)
6
8
5.64 7.95
3.46 0.02
0.06 0.00
9.64 12.70
38.98 14.70
0.00 0.00
8.56 9.75
55.82 79.16
2.10 0.40
5.38 5.75
44.00 58.44
12.35 11.55

10
25
7.95 10.20
0.07
0.11
0.00
0.00
12.70 14.60
0.12
0.00
0.00
0.00
9.80
9.85
99.89 99.89
0.00
0.00
5.70
7.35
82.30 106.70
10.55 8.05

Figure 14 illustrates the inverse relationship observed between acetate
concentration in the media and OD. The greater the concentration of glucose batched
upfront for each culture led to a greater concentration of acetate in the media, which
resulted in lower overall cell growth. Additionally, it was determined that 20 g/L glucose
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was more than the culture could metabolize over 25 hours. Conversely, the culture
batched with 10 g/L glucose had fully metabolized the sugar source over the same period
of time. This is shown in Figure 15.

Figure 14. Acetate and growth profiles of 1A2 cultures grown in City Broth with 5, 10,
and 20 g/L glucose. Acetate accumulation was observed in the media with 10 and 20 g/L
glucose (shown in blue and orange, respectively).
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Figure 15. Acetate and glucose profiles of 1A2 cultures grown in City Broth which were
batched upfront with 10 and 20 g/L glucose.
Based on this preliminary experiment it was determined that the starting
concentration of glucose for experiments moving forward would be 10 g/L (1% w/v).
This concentration was sufficient to lead to acetate accumulation in the wild-type cells,
however did not overwhelm the system such that the glucose could not be fully
metabolized.
5.1

Constitutive arm (pACYC177)
Each of the eight mlc constructs was evaluated under constitutive expression in

the pACYC177 plasmid transformed in the 1A2 host strain. Shake flask cultures were
carried out in LB with 0 and 10 g/L glucose. Additionally, overnight cultures were
conducted in City Broth with 10 g/L glucose. OD550 and acetate concentration from these
experiments can be found in Tables 8, 9, and 10. No acetate accumulation was observed
in the cultures in which no glucose was initially charged. However, in both cohorts
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batched with 10 g/L glucose, significant acetate accumulation was observed by the
endpoint for all mlc variants. Greater acetate accumulation was observed in the cultures
grown in City Broth compared to those grown in LB.
Table 8. Overnight shake flask cultures of pACYC177 containing an mlc insert
(constitutively expressed) transformed into 1A2 cells. Cells were grown in strictly LB
media (no glucose). A, B, and C refer to sampling time points. A was taken between 3-4
hours post inoculation, B 6-7 hours, and C 23-29 hours.

GTG
GTG-His
GTG-R52H
GTG-R52H-His
ATG
ATG-His
ATG-R52H
ATG-R52H-His
wild-type 1A2

A
1.46
1.50
1.50
1.48
1.89
1.46
1.85
1.91
2.82

OD550
B
3.72
3.73
3.73
3.65
2.77
3.06
--2.58
3.86

C
3.28
3.52
3.14
3.28
2.38
3.40
--2.32
3.24

Acetate (mM)
A
B
C
1.62
0.25
0.40
1.82
0.00
0.30
1.69
0.00
0.25
2.25
0.00
0.35
2.62
0.00
0.13
1.65
0.29
0.32
2.70
----3.05
0.29
0.12
0.00
0.00
0.00

Table 9. Overnight shake flask cultures of pACYC177 containing an mlc insert
(constitutively expressed) transformed into 1A2 cells. Cells were grown in LB and 10
g/L glucose. A, B, and C refer to sampling time points. A was taken between 3-4 hours
post inoculation, B 6-7 hours, and C 23-29 hours.

GTG
GTG-His
GTG-R52H
GTG-R52H-His
ATG
ATG-His
ATG-R52H
ATG-R52H-His
wild-type 1A2

A
1.54
1.53
1.75
1.78
1.65
1.45
1.82
1.90
2.64

OD550
B
2.47
2.71
2.41
2.19
2.38
3.45
2.13
2.51
2.77
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C
2.78
2.74
2.78
2.46
2.66
4.36
2.18
2.90
3.40

Acetate (mM)
A
B
C
10.65 17.90 38.96
11.02 18.56 38.91
9.81
13.92 39.46
10.34 15.19 45.60
11.32 17.94 39.63
9.62
9.16
29.68
10.87 14.54 41.73
10.53 12.96 45.24
6.82
16.24 44.24

Table 10. Overnight shake flask cultures of pACYC177 containing an mlc insert
(constitutively expressed) transformed into 1A2 cells. Cells were grown in City Broth
and 10 g/L glucose. A, B, and C refer to sampling time points. A was taken 4 hours post
inoculation, B 7-8 hours, and C 25-30 hours. GTR: Greater than reportable,
concentration greater than 103 mM.

GTG
GTG-His
GTG-R52H
GTG-R52H-His
ATG
ATG-His
ATG-R52H
ATG-R52H-His
wild-type 1A2
5.2

OD550
A
B
C
4.76 11.36 14.12
5.00 9.96 12.80
4.85 9.96 12.08
5.00 10.60 13.52
4.40 6.54 7.64
4.26 7.16 8.08
4.81 8.88 10.56
5.10 12.02 15.44
6.32 9.75 9.85

Acetate (mM)
A
B
C
27.09
86.98 GTR
26.65
92.28 GTR
29.96
82.65 GTR
31.45
83.13 GTR
27.14
62.04 GTR
24.39
66.69 GTR
32.05
85.57 GTR
34.87
81.66 GTR
28.81
79.16 99.89

Inducible arm (pLMG17)
A series of shake flasks cultures was conducted to determine the time point in

which the inducer, IPTG should be added to maximize the effect Mlc overexpression has
on the culture. The wild-type mlc sequence (GTG) was used in the pLMG17 plasmid
with host 1A2 and grown in City Broth and 10 g/L glucose. Three different conditions
were evaluated: no IPTG was added, 3 mM IPTG was added four hours post-inoculation,
and 3 mM IPTG was added eight hours post-inoculation. A culture of wild-type 1A2
cells was grown as a control. Table 11 shows the OD550, acetate, and glucose
concentrations measured over the course of these overnight cultures.

38

3 mM IPTG added
at time point

Table 11. 3 mM IPTG was added to cultures of E. coli that had been transformed with
the inducible plasmid pLMG17 containing the GTG mlc construct. The 1A2 host strain
was used and grown with City Broth and 10 g/L glucose. No IPTG was added to the
wild-type control culture.

n/a
4 hr
8 hr

1A2 Wildtype control

OD550
Acetate (mM)
Glucose (g/L)
OD550
Acetate (mM)
Glucose (g/L)
OD550
Acetate (mM)
Glucose (g/L)
OD550
Acetate (mM)
Glucose (g/L)

4
2.46
9.40
9.40
2.30
9.60
9.55
2.20
10.14
9.65
6.40
51.10
4.30

8
11.20
32.44
3.75
9.90
29.41
3.40
11.80
26.10
4.00
5.65
106.3
0.50

10
15.95
55.87
0.00
14.40
64.35
0.00
14.60
54.61
0.10
8.00
136.7
0.50

Time (hr)
12
16.15
28.20
0.00
14.75
27.84
0.00
15.75
26.62
0.00
8.45
140.2
0.00

14
16.10
0.54
0.00
15.20
0.00
0.00
15.90
0.28
0.00
8.65
133.3
0.00

16
15.60
0.31
0.00
14.95
0.00
0.00
16.20
0.00
0.00
8.95
132.0
0.00

24
15.50
0.00
0.00
14.15
0.00
0.00
14.40
0.00
0.00
8.50
137.9
0.00

In each of the cultures transformed with the pLMG17 plasmid, no acetate
accumulation was observed after 24 hours, although a moderate peak was observed at 10
hours. Conversely, the wild-type 1A2 culture showed an immediate rise in acetate
concentration in the media at the 4 hour mark and continued to remain high throughout
the duration of the culture. This is illustrated in Figure 16. Although there was greater
growth in the control group initially, its growth stalled out after 10 hours, never reaching
above 9 OD550, whereas the entire pLMG17 group measured above 15 OD550 after 14
hours.

39

Figure 16. Acetate profiles from pLMG17 mlc induction experiment.
Next, each of the eight mlc constructs was evaluated in the pLMG17 plasmid with
1A2 as the host stain. Overnight shake flask cultures were run in duplicate for each
construct; City Broth media was used and 10 g/L glucose batched upfront. Acetate and
growth profiles from these experiments are shown in Figures 17 through 19. A culture of
wild-type 1A2 was grown as a control. Data shown in the figures is presented as an
average of the replicates unless otherwise stated. A complete listing of all the growth,
acetate and glucose data collected can be found on Table 14 in Appendix F.
During this first set of experiments in which mlc constructs were expressed via
the pLMG17 vector in City Broth, significant variability was observed in the acetate
profiles over the course of the 24 hour cultures, as shown in Figure 17. Even though each
of the cultures overexpressing Mlc showed lower levels of acetate accumulation in the
media compared to the 1A2 control culture, some only showed reduced levels of acetate,
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whereas others showed near elimination; the cultures representing the latter group are
highlighted in Figure 18.

Figure 17. The average acetate profiles for each mlc constructs expressed through
pLMG17 in City Broth and 10 g/L glucose. 1A2 was used as the host strain.
The GTG, GTG-R52H, GTG-R52H-His, and ATG-His mlc constructs showed
minimal acetate production and accumulation when overexpressed via the pLMG17
expression vector and transformed in the 1A2 host strain. Figure 18 shows the acetate
profiles of both replicates for these four mlc constructs. Though minimal levels of
acetate are reached by the 16 hours mark, variability in the profiles can be seen for each
pair.
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Figure 18. A closer look of the acetate profiles of the mlc constructs which yielded the
lowest amounts of acetate accumulation when grown in City Broth and 10 g/L glucose.
Data shown is both of the replicate shake flask cultures grown for each construct.
Each of the cultures overexpressing Mlc grew to a greater OD than the 1A2
control; this is illustrated in Figure 19. In general the growth profiles show an inverse
relationship with the acetate concentration in the media. The four mlc constructs
highlighted in Figure 18 for the lowest acetate concentrations also reached the greatest
OD.
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Figure 19. Growth profiles of overnight shake flask cultures overexpressing Mlc in 1A2
grown in City Broth and 10 g/L glucose.
In each of the eight experimental cases, a decrease in acetate accumulation in the
media was observed compared to the wild-type 1A2 culture. This decrease was
particularly significant in four cases, highligted in Figure 18; the wild-type mlc sequence
(GTG), the R52H point mutation with and without the histidine tag (GTG-R52H and
GTG-R52H-His), and the change in start codon paired with the histidine tag (ATG-His).
In each of these cultures, the peak acetate found in the media did not exceed 40 mM, and
any acetate produced was nearly fully metabolized by the 16 hour mark. For the control
culture, acetate concentration plateaued around 130 mM by the 12 hour mark and was
relatively steady for the remainder of the experiment.
Prior to running cultures on the DASGIP bioreactor system, each of the four mlc
constructs identified to best limit acetate accumulation was co-transformed with the
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plasmid encoding for TPA in 16C9 host cells, pTPA. Each of the four cotransformations were grown in shake flask cultures with CRAP media and batched
upfront with 10 g/L glucose. Each was run in duplicate. A culture of 16C9 cells cotransformed with pTPA and a blank pLMG17 plasmid (no mlc insert) was used as a
control. The growth and acetate profiles of these runs are shown in Figures 20 and 21,
respectively. The figures shown represent an average of the replicate shake flask
cultures, unless otherwise stated. A complete table of growth, acetate, and glucose data
can be found on Table 15 in Appendix F.
The four cultures co-expressing Mlc appear to reach the exponential growth phase
about two hours after the control culture as shown in Figure 20. Additionally, three of
the four Mlc cultures reached greater OD than the control. The culture expressing the
GTG mlc construct appeared to reach a similar growth plateau as the control culture,
approximately 4 OD.

Figure 20. Growth profile of shake flask cultures producing Mlc and TPA in CRAP
media and 10 g/L glucose.
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Similar to the previous set of experiments, an inverse relationship was observed
between the growth and acetate profiles; the greater the acetate concentration in the
media, the lower the overall density of the culture. Figure 21 shows the acetate profiles
of each of the cultures co-expressing Mlc with TPA along with the control culture. The
data is shown as an average of the two replicate cultures with exception to the culture
containing the GTG-R52H-His mlc construct (shown in purple), in which acetate profiles
for both replicates are shown. Significant variance in the acetate profile was observed in
this particular set of replicates after the eighth hour.

Figure 21. The GTG-R52H-His mlc construct yielded the least acetate accumulation over
a 16 hour culture when co-expressed with TPA in C.R.A.P media and 10 g/L glucose.
Individual data sets from each GTG-R52H-His/pTPA replicate are shown.
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RT-qPCR analysis was performed to compare levels of mlc transcription during
the course of the cultures. Samples were collected 6, 8 and 10 hours post inoculation. At
a minimum a tenfold increase of mlc RNA was observed in the cultures overexpressing
Mlc compared to the control, however greater increases were certainly observed as seen
in Figure 22. Once again, the data sets for both cultures containing the GTG-R52H-His
mlc construct are shown due to significant variation in the replicate pair. The decrease in
mlc RNA content in the “B” replicate at the 8 hour time point corresponds with the
increase in acetate concentration in the media, as shown in Figure 21.

Figure 22. RT-qPCR results comparing mlc expression relative to two housekeeping
genes 6, 8 and 10 hours post inoculation. Individual data sets from each of the GTGR52H-His/pTPA replicates are shown.
Based on the data collected from the shake flask experiments the cotransformation containing the GTG-R52H-His mlc construct was selected to be run in the
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DASGIP bioreactor system. In addition to consistently exhibiting the greatest effect on
minimizing acetate accumulation in culture, the histindine tag would allow for protein
detection via Western blot or in-gel staining.
A total of six fermentation runs were conducted as listed on Table 5. Four runs
expressed both Mlc and TPA (JB017, JB018, JB024, and JB026), and two were part of
the control group (JB023 and JB025). Each run was carried out for 36 hours and a
glucose excursion was executed after a consistant glucose feed rate was established
(between 18-24 hours post-inoculation) for runs JB018, JB025, and JB026. Glucose,
acetate and growth profles from this set of experiments are presented in Figures 23
through 28. Each profile is shown twice, the first over the course of the entire 36 hour
run, and a second focusing on the initial 16 hours. A complete list of all growth, acetate,
glucose, and RNA data from the DASGIP experiments can be found on Table 16 of
Appendix F.
The glucose profiles of the six DASGIP runs show an accumulation of glucose in
those cultures co-expressing Mlc. This is illustrated in Figures 23 and 24. The maximum
glucose concentrations were observed between 8 and 12 hours post-inocullation, with the
greatest concentration of 26 g/L occuring during run JB024. The other cultures coexpressing Mlc experienced glucose peaks around 10-15 g/L. Each of the Mlc culutres
required manual adjustments to the glucose feeding algorithm (GFA) to prevent further
glucose accumulation. It is important to note, that although the concentration of glucose
in the control cultures (JB023 and JB025) appear to be low, glucose was fed into the
cultures, however instead of accumulating in the media, it was rapidly being consumed.
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Over the initial several hours of the runs more glucose was fed into the control cultures,
than in those co-expressing Mlc (data shown in Appendix G).

Figure 23. Profile of glucose present in the media over the entire 36 hours of the
fermentation. An accumulation of glucose was observed in each of the runs coexpressing Mlc, whereas no such accumulation was observed in the controls.

Figure 24. Profile of glucose present in the media over the first 16 hours of the
fermentation.
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Significant acetate accumulation was observed in the two control cultures (JB023
and JB025) as well as in one of the cultures co-expressing Mlc (JB024), as illustrated in
Figures 25 and 26. The onset of acetate accumulation during the JB024 run was delayed
by approximately 12 hours compared to the controls. A rise in acetate concentration was
also observed after 30 hours; this was most prominent in the control cultures.
Runs JB017 and JB018 each had peak glucose concentrations in the media of
close to 10 g/L (similar to the shake flask cultures), and no appreciable rise in acetate
concentration in the media was observed. Run JB026, had a slightly higher peak glucose
concentration in the media of 15 g/L, which resulted in a small spike in acetate (20 mM)
at the 16 hour mark (similar to what was seen in the shake flask cultures).

Figure 25. Profile of acetate present in the media over the course of the 36 hour
fermentation.
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Figure 26. Acetate levels remained low in cultures overexpressing Mlc during the first
16 hours (JB017, JB018, JB024, and JB026).
The growth profiles for the six DASGIP bioreactor runs are shown in Figures 27
and 28. The two control cultures (JB023 and JB025) initially out grow those cultures
over-expressing Mlc, presumably as a result of the rapid consumption of all available
glucose. However after eight hours, the growth rates of the control cultures slow down;
the timing coincides with the accumulation of acetate in the media. Although the growth
of the cultures overexpressing Mlc initially lag behind the controls, all of the runs achieve
comparable OD by the completion of the 36 hour experiment; each surpassing 100 OD
after 27 hours.
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Figure 27. Growth profiles from cultures run on DASGIP bioreactor system.

Figure 28. Growth profiles of the cultures during the initial 16 hours.
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RT-qPCR was performed on samples collected 8 and 12 hours post-inoculation to
quantify the level of mlc transcription. These results are shown in Figure 29. Each of the
cultures co-expressing Mlc showed a significant increase in mlc RNA compared to the
controls. At a minimum, a nearly 100-fold increase was observed in the Mlc cultures.
An assay was also run to determine the concentration of TPA produced
throughout the course of the fermentation. Samples were collected 24 and 36 hours postinoculation. These results are shown in Figure 30. After 24 hours, there were no clear
trends separating the cultures co-expressing Mlc from the controls, however after 36
hours, an average 1.7-fold increase in total TPA production was measured in the cultures
expressing Mlc compared to the control.

Figure 29. Relative expression of mlc normalized to two house keeping genes at 8 and 12
hours post inoculation.
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Figure 30. Therapeutic Protein A titer from DASGIP bioreactor cultures.
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CHAPTER SIX: DISCUSSION
6.1

Constitutive Arm (pACYC177)
The growth and acetate data from the experiments constitutively expressing Mlc

showed no appreciable difference between the wild-type culture and those cultures
overexpressing Mlc. The control experiment in which no glucose was added showed
similar growth between both groups after 24 hours and no significant acetate
accumulation, as seen in Table 8. In the two sets of experiments in which 10 g/L glucose
was batched up front, shown in Tables 9 and 10, respectively, acetate accumulation was
observed after 4 hours in all cases and continued to rise through the course of the
experiments.
The experimental data suggest that there was not enough Mlc being produced
through the pACYC177 expression vector to positively affect acetate accumulation in
culture. Although constitutively expressed, pACYC177 is a low copy number plasmid
and in these instances was not able to provide a sufficient Mlc response to mitigate
acetate accumulation due to the overfeeding of glucose, thus closing this arm of
experiments.
6.2

Inducible Arm (pLMG17)

6.2.1

Inducer Evaluation
Data from the induction experiment, presented in Table 11 and illustrated below

in Figure 31, show similar glucose and acetate profiles from each of the cultures carrying
the pLMG17 plasmid regardless of when IPTG was added, if at all. This induction
experiment did show however, a slower depletion of glucose and significant acetate
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reduction from the media compared to the 1A2 control culture. The control culture did
not achieve a measured optical density greater than 9 (OD550) and the acetate
concentration in the media reached a plateau around 130 mM. This suggested that Mlc
was expressed from the pLMG17 expression plasmid regardless of the addition of the
inducer, and minimized acetate accumulation while positively affecting overall cell
growth.

Figure 31. The addition of IPTG to the culture did not appear to affect the growth or
acetate profiles of the cultures. The control culture reached an OD550 of 9, and acetate
concentration reached a plateau around 130 mM.
The tac promoter, which regulates transcription of mlc in the pLMG17 expression
vector, is not completely repressed and does allow for some residual basal levels of
expression [32]. The leaky nature of the tac promoter appeared to allow sufficient
transcription of mlc without an inducer, which positively affected the glucose, acetate and
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growth profiles of the cultures. Based on this finding, IPTG was not used in subsequent
experiments with the pLMG17 expression plasmid.
6.2.2

Mlc Overexpression in Overnight Cultures
The first set of experiments in which the eight mlc constructs were overexpressed

via the pLMG17 expression vector yielded varying concentrations of acetate
accumulating in the media as seen in Figure 17. Each culture overexpressing Mlc
showed lower concentrations of acetate in the media compared to the 1A2 control culture,
suggesting that Mlc, when overexpressed, can limit the glucose uptake into the cell and
mitigate the formation of acetate. The variability in the acetate profiles between each of
the Mlc cultures, however, intimates variability in the level of overexpression of Mlc.
This may have been the result of basing the transcription of mlc on the leakiness of the
tac promoter. Although no significant variation was observed in the growth and acetate
profiles during the induction experiment, the dynamic nature of E. coli culture may have
resulted in varying levels of “leaky” transcription.
The general trends in the growth and acetate profiles are in line with what Cho et
al. observed when overexpressing Mlc in culture [11]. In both experiments the cultures
overexpressing Mlc reached greater cell density compared to the wild-type, as illustrated
in Figures 11 and 19. Additionally, the acetate concentration in the media continued to
rise in the wild-type culture while they trended downward (and in some cases were nearly
eliminated) in the Mlc cohort, as shown in Figure 17.
Through the first series of shake flask experiments grown in City Broth media,
cultures overexpressing Mlc with the GTG-R52H and GTG-R52H-His constructs closely
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paralleled one another. As shown in Figure 32, the growth profiles from these two
constructs approached 18 OD550 and acetate found in the media peaked prior to the 10
hour mark and was mostly depleted three hours later. These results were expected, the
histidine tag was only added to the end of the mlc sequence for analysis. It was not
intended to affect Mlc expression [25] nor appears that is has.

Figure 32. Growth and acetate profiles from cultures overexpressing Mlc containing the
R52H point mutation with and without a histidine tag.
6.2.3

Co-Expression of Mlc with TPA
A couple of differences were observed when comparing the growth and acetate

profiles between the cultures solely expressing Mlc, illustrated in Figures 17-19, and
cultures co-expressing Mlc along with TPA, shown in Figures 20 and 21. Firstly, the
latter group only reached half the OD as the cultures growing in City Broth. This is
likely the result of the combination of several factors: media, (CRAP media versus City
Broth), host strain (16C9 versus 1A2), and lastly the extra burden of expressing TPA
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along with Mlc. The selection of media and host strain were based on past experiments
targeting TPA production.
It is important to note that although the first set of experiments reached a higher
OD, both groups exhibited similar growth, reaching stationary phase after 12 hours.
Conversely, the acetate profiles for the two experiment groups differ, for the group coexpressing TPA, the acetate concentration in the media was still on the rise after 16
hours, whereas when Mlc was solely overexpressed in culture, the acetate concentrations
had already diminished after 16 hours. This can be seen in Figures 18 and 21.
The deviation in acetate profiles may be explained by the slower growth rate of
the group co-expressing Mlc and TPA. Due to the slower growth, glucose remained in
the media for a much longer period of time. After 16 hours there was still glucose
present in all but one of the cultures, whereas in the previous experiment (solely
overexpressing Mlc), all of the glucose in the media has been consumed 13 hours postinoculation. This is shown in Figure 33. Though the concentration of glucose that was
batched upfront was the same for both groups of experiments (10 g/L), the slower growth
rate for the cultures co-expressing Mlc and TPA resulted in a higher glucose burden for
the cells (i.e. a higher glucose concentration when normalized for cell density). Based on
the trend lines, glucose levels should have likely been depleted after 20-24 hours post
inoculation; it is after this point that a direct comparison between acetate levels should be
made.
The glucose profiles across both sets of experiments illustrated in Figure 33, show
a significant change in the glucose consumption rate in four of the cultures: 1A2
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(control), pLMG17/pTPA (control), GTG/pTPA, and ATG-His. The timing of this
change in glucose consumption rate corresponds to the cultures transitioning to the
stationary phase of growth, which can be seen in Figures 19 and 20. Additionally, each
of these four cultures exhibited the highest concentration of acetate in the media,
suggesting that the change in glucose consumption rate may correspond to the point in
which the acetate accumulation in the media was significant enough to stunt overall cell
growth.

Figure 33. A comparison of the concentration of glucose in the media between the two
sets of experiments. The data presented in dotted lines represents the glucose profiles for
those cultures co-expressing Mlc and TPA, the solid lines are only producing Mlc.
Despite the differences in growth rate and glucose concentration in the media, the
GTG-R52H-His mlc construct performed well both when solely overexpressed and coexpressed with TPA in culture. In the second experiment (when co-expressed with TPA)
there was appreciable variability in the data between the two replicates, as seen in Figure
21. Replicate A only showed baseline levels of acetate, while acetate levels in the media
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for replicate B climbed after 6 hours, but still did not surpass 40 mM. Though after 16
hours, the acetate levels were on the rise, the glucose concentration in the media was
already approaching 2 g/L, which suggests that the acetate concentration in the media
would soon peak at a maximum concentration that was nearly half of what was measured
in the other three mlc constructs tested.
Unlike the previous experiment in which Mlc was solely overexpressed in culture,
the GTG-R52H-His and GTG-R52H mlc constructs did not share similar growth and
acetate profiles when transformed via the pLMG17 plasmid and co-expressed with TPA.
The untagged construct performed similarly to the other two constructs tested in this set
of experiments, with a rapidly rising acetate profile, exceeding 70 mM after 16 hours. It
was also the first of the cohort to completely consume all of the glucose in the media,
shown in Figure 33 (green dotted line). The differences in the growth and acetate profiles
of the histidine tagged and untagged constructs are illustrated in Figure 34.

Figure 34. Growth and acetate profiles for cultures co-expressing Mlc and TPA. The
mlc constructs include the R52H point mutation with and without a histidine tag.
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The expectation was that these two constructs would have behaved similarly such
as they did in the first round of experiments, depicted in Figure 30, proving that the
histidine tag did not affect Mlc expression or activity. Since the tagged construct
outperformed the untagged, this deviation is likely not a result of the histidine tag, but
rather related to the variation in acetate profiles that has been observed between the
different mlc constructs throughout all of the experiments; which is hypothesized to be
the result of mlc transcription based on the leaky regulation of the tac promoter.
Although the precise reason for the variation observed in the growth and acetate
profiles is under investigation, it is important to note that in each of the experiments,
those cultures overexpressing Mlc (either as a single or co-transformation) outperform
the wild-type controls. To “outperform” in this context can be defined as achieving
greater optical density and lower acetate accumulation in the media as a result of slower
glucose uptake. This has been illustrated in Figure 17 and Figures 19-21 and is consistent
with the results presented by Cho et al. [11].
Two methods were used to verify that the results obtained were caused by the
overexpression of Mlc, protein detection via the histidine tag and RNA detection via RTqPCR. Three different techniques were used to detect the histidine tag (two by Western
blot and a third by in gel staining). The limit of detection of these three techniques was
as low as 0.5 ng, however none were successful in resolving the Mlc band. It was
concluded that although there was sufficient overexpression of Mlc to reduce acetate
accumulation it was not enough to detect the attached histidine tag.
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Although direct detection of the Mlc protein was not successful, the indirect
measurement via RT-qPCR provided sufficient evidence that the observed effects on
acetate accumulation and cell growth were the product of Mlc overexpression. RNA
analysis, such as is shown in Figure 22, consistently showed increased levels of mlc RNA
in the overexpressing cultures compared to nominal levels found in the control groups.
Additionally, increased mlc RNA levels corresponded with lower acetate
concentrations in the media. This is most evident when comparing the GTG-R52H-His
construct with the blank pLMG17 plasmid control as illustrated in Figure 35. The
greatest presence of mlc RNA corresponds to the highest cell density, and lowest
concentration of acetate. This general trend however, was not consistent in all cases.
The ATG-His construct appears to have the second highest concentration of mlc RNA
while only the third lowest acetate concentration. This may be the result of the state of
growth the culture is in (exponential versus stationary), and while this deviation cannot
be explained given the analysis performed, the results still demonstrates the relationship
between the overexpression of Mlc and reduced acetate accumulation. Moreover, the
GTG-R52H-His construct has consistently demonstrated the greatest impact on acetate
accumulation in shake flask cultures and was selected as the best candidate to move
forward for small scale bioreactor evaluation.
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Figure 35. Measured growth, acetate and RNA levels after 10 hours in culture. 16C9
cells were co-transformed to overexpress Mlc and TPA.
6.2.4

Small Scale Fermentation in DASGIP Reactors
The transition from growing cultures in shake flasks to the DASGIP reactor

system was made to better model the conditions in which therapeutic proteins are
produced. The DASGIP reactor is inherently a different system and allows for much
higher cell density cultures to grow compared to the shake flask. One significant
difference is the availability of oxygen; where in the shake flasks it is in excess, the
DASGIP systems is driven by a glucose feed algorithm (GFA) used to maximize cell
densities and ultimately control the cultures under micro-aerobic conditions (dO2
control).
Significant differences in the cell growth, acetate, and glucose profiles between
the Mlc and control cultures were observed particularly during the first 16 hours of the
DASGIP bioreactor runs. As the cultures entered into the exponential stage of growth,
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the control cohort experienced more rapid growth rate represented by the steeper slope
between hours 4 and 8 in Figure 28. This increased growth rate corresponded with the
rapid depletion of glucose in the media shown in Figure 24, and the beginning of a rise in
acetate in the media, shown in Figure 26.
Those cultures overexpressing Mlc experienced a much slower growth rate, which
can be attributed to the slower uptake of glucose into the cells. This resulted in lower
acetate accumulation in the media, and an unexpected rise in the glucose concentration.
The rise in glucose was the result of the glucose feeding algorithm (GFA) attempting to
establish an appropriate glucose feed rate (GFR) to support cell growth. Due to the
slower glucose uptake in the Mlc cultures a manual intervention was required to reset the
GFR because the GFA was overfeeding the cultures. Once manually reset, the GFA
operated appropriately. Moving forward, the GFA should be optimized to better respond
to the slower glucose uptake rate when Mlc is overexpressed in culture.
Despite the overfeeding caused by the GFA, three of the four cultures coexpressing Mlc presented a minimal acetate response in comparison to the two control
cultures (JB023 and JB025). Only in one instance was an appreciable acetate response
detected in a culture expressing Mlc, JB024, which had experienced a significant glucose
overfeeding event due to the GFA. In each of these four cultures RT-qPCR data, shown
in Figure 29, confirmed increased levels of mlc RNA compared to the controls. Similar
to the results seen with the shake flask cultures, the overexpression of Mlc appears to
mitigate acetate formation due to glucose overfeeding.
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It is interesting to note that although JB024 underwent the overfeeding event from
the onset of the culture, peaking at 8 hours, the acetate response was delayed, beginning
after 15 hours and peaking at 24 hours. This was unlike the control cultures, which
underwent an acetate response nearly immediately, peaking at 12 and 7 hours for JB023
and JB025, respectively. Upon review of the dissolved oxygen levels throughout these
runs (data not shown), it appears that the acetate event observed during JB024 coincided
with when the culture was reaching dO2 control. This suggested that the acetate formed
was not a direct result of overfeeding but may have been a consequence of the microaerobic conditions that impacted the aerobic respiration pathway and drove the formation
of acetate. In addition, this culture condition may have exceeded the capacity of the
overexpressed Mlc to slow the glucose uptake sufficiently.
This response is linked to the overexpression of Mlc and the overfeeding event,
however is not a direct result of solely the overfeeding event, which can explain the lower
peak concentration of acetate compared to those observed in the control runs. The
overexpression of Mlc slowed the uptake of glucose into the cells resulting in a slower
growth rate. However, due to the GFA a surplus of glucose had already been charged
into the media, though it remained there as the culture slowly metabolized what it could.
Close to the 15 hour mark the cell mass had increased enough that it was able to reach
micro-aerobic conditions. Under typical operation the GFA would control the GFR to
maintain a balance between growth and dO2 content, however the glucose had already
been charged in the media, forcing the culture into micro-aerobic conditions with excess
glucose present which resulted in acetate production.
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The acetate accumulation observed in the control cultures (JB023 and JB025) was
a not a product of micro-aerobic conditions, but rather the overfeeding of glucose. There
was no glucose accumulation in the media, though the GFA was feeding the cultures,
which means cells were freely metabolizing any and all glucose available. Also the
acetate events in the control cultures occurred before dO2 control was achieved, which
would mean the cultures were undergoing aerobic respiration as the TCA cycle became
overwhelmed with pyruvate, driving the formation of acetate via the Pta-Ack pathway.
The objective of the glucose excursions conducted in the DASGIP bioreactor
cultures was to produce a change in acetate concentration in the media caused by an
overfeeding event. A 20% increase in the GFR was performed for 10 minutes once dO2
control was established in the cultures. For run JB018 this occurred after 18 hours, for
the remaining cultures (JB025 and JB026), after 24 hours. The results from the glucose
excursions were inconclusive. Glucose concentrations in the media just before and after
the excursions were near zero and no significant differences were observed between runs
where an excursion was conducted and the controls (data not shown). This is most likely
due to the glucose feed algorithm (GFA), which establishes the GFR to maintain an
oxygen limited environment.. Under these conditions a 20% increase in the GFR for 10
minutes may have only created a momentary overfeeding event that the culture could
withstand with minimal disruption. A prolonged excursion and/or greater increase in the
GFR may have been required to fully evaluate the effect the overexpression of Mlc had
once the culture was under dO2 control.
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Additionally, the acetate profiles after the glucose excursion was initiated,
presented in Figure 36, show a rise in JB025 several hours after the glucose excursion. A
similar but smaller rise is also observed in JB023, the corresponding control culture that
did not undergo a glucose event. None of the cultures overexpressing Mlc experienced
any significant rise in acetate levels. It is difficult to attribute the rise in acetate observed
in JB025 with the glucose excursion, because a rise was observed in the control, however
the increase in acetate may be a general indication of the health of the culture. Both of
these cultures (JB023 and JB025) had significant acetate events within the first 16 hours
due to glucose overfeeding and as a result may have been entering the end stage of
growth as indicated by the accumulation of acetate. The rise in acetate also corresponded
with a decrease in cell density from the 30 to 36 hour marks as shown in Figure 27. More
experimentation is required to fully evaluate the effect overexpressing Mlc in culture can
have on a glucose overfeeding event.
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Figure 36. Acetate profiles for cultures after a 10 minute glucose excursion was executed
for runs JB018, JB25, and JB026.
The final TPA production from the DASGIP bioreactor cultures, shown in Figure
30, indicate that after 36 hours those cultures overexpressing Mlc produced greater
concentrations of the therapeutic protein. On average, cultures co-expressing Mlc
produced 1.7 times more TPA after 36 hours than cultures solely producing TPA; the best
case (JB018) produced 2.3 times greater TPA than the control group. At the 24 hour
mark, the cultures overexpressing Mlc were producing less TPA than the controls, likely
due to the lower cell densities caused by the slower glucose uptake.
The production of TPA occurs over the course of the culture; taking the total TPA
produced and normalizing to the integrated OD (iOD) of the culture, the group
overexpressing Mlc shows a 1.7 times greater TPA production compared to the control
group. This suggests that the overexpression of Mlc in culture may allow for greater
cellular production of TPA, not just improved production as a result of higher cell
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densities. In fact, two of the runs JB024 and JB026 had an overall iOD less than that of
the control cultures, but yet still produced more overall TPA. The iOD for JB024 and
JB026 are 2097 and 2196 versus 2413 and 2492 for JB023 and JB025, respectively. Due
to variations in the GFR, including the initial overfeeding and glucose excursions,
additional experiments would need to be conducted in order to draw any further
conclusions directly correlating the affect the overexpression of Mlc has on the
production of TPA.
The greater production of TPA in conjunction with overexpressing Mlc was
consistent with the findings of Cho et al. [11]. Cho et al. found four times greater ßgalactosidase activity and 10 times greater fluorescents when overexpressing Mlc
compared to the wild-type strain, while only approximately 1.5 times greater cell growth
was observed.

This observation suggested greater recombinant protein production

beyond an improvement in cell mass. The degree of improvement in recombinant protein
productivity between this experiment and the results published by Cho et al. (1.7-fold
compared to 4 and 10-fold) may be the result of the greater burden of expressing TPA via
the co-transformation of two plasmids (one expressing TPA and the other Mlc), whereas
Cho et al. had made changes to the endogenous mlc sequence thus requiring only the
transformation of a single plasmid for recombinant protein expression. Additional
experiments are required to correlate the overexpression of Mlc with the productivity of a
recombinant therapeutic protein.
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6.2.5

Further Experimentation
Based on the results from this series of work, several additional steps are required

in order to better evaluate how the overexpression of different Mlc variants in E. coli
culture affects production and accumulation of acetate. These steps include the selection
of an appropriate expression plasmid, co-expression of alternate recombinant proteins,
optimization of the glucose feed algorithm and glucose excursion used in the small scale
fermentation, and procurement of an Mlc-specific anti-body.
First and foremost the selection of an appropriate expression plasmid is required
for the proper evaluation of Mlc overexpression. In work completed, the constitutively
expressed plasmid did not drive high enough Mlc expression, likely due to being a lowcopy number plasmid. The inducible plasmid evaluated allowed for the transcription of
mlc without the addition of an inducer caused by the leaky regulation of the tac promoter.
Additionally, the experiments conducted showed that wild-type E. coli cultures rapidly
consume any glucose available, leading to acetate formation and accumulation.
Therefore, the plasmid selected to drive Mlc overexpression for future experiments
should confer constitutive expression of Mlc via a high-copy number plasmid. The level
of Mlc overexpression through this plasmid should remain consistent through the
lifecycle of the culture.
After the selection of an appropriate expression plasmid, the evaluation of the
four mlc constructs (GTG, GTG-R52H, ATG, and ATG-R52H) can be repeated. The
plasmids should be transformed into 1A2 cells, and cultures grown in City Broth with 10
g/L glucose. A culture of 1A2 cells with a “blank” plasmid (no mlc insert) should be
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used as a control. Cell growth, acetate, and glucose profiles should be analyzed to
compare the effect each of the mutations has relative to that of the endogenous mlc
sequence (GTG). Based on these results, at least one mlc construct should be selected to
be co-transformed along with pTPA in order to study the effect the overexpression of Mlc
has on the production on a therapeutic protein.
In addition to co-transforming cells with a plasmid encoding for TPA, another
series of experiments in which either pGAL or pGFPuv is co-transformed along with the
plasmid encoding for Mlc would bridge the work performed by Cho et al [11]. This
effort would help determine if genomic modulation of mlc leads to greater recombinant
protein production compared to overexpression of Mlc through an expression plasmid.
The glucose feed algorithm used in the small scale fermentation experiments
needs to be modified to account for the slower glucose uptake rate by the cultures
overexpressing Mlc. The current algorithm currently overshoots the initial glucose feed
rate during the early stages of the culture such that dO2 control cannot be achieved
without manual intervention. A modified algorithm could minimize the overshoot thus
creating a minimal overfeeding event.
Additionally for the glucose excursion test, preliminary experiments should be
run to determine the percent increase in glucose feed rate and duration of the excursion
that would be required to initiate an acetate response in a wild-type culture. More
frequent sampling immediately following the glucose excursion should be conducted,
starting at every 10-15 minutes for the first hour.
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Lastly, acquiring purified Mlc protein and anti-Mlc mouse antibody for use with
Western Blot analysis would help confirm the expression level of Mlc. This approach
will allow for the direct detection of the Mlc protein and bypass the need for a histidine
tag. Not only would this confirm successful translation of Mlc, but the ability to quantify
the Mlc content would help determine if the concentration of Mlc was fluctuating
throughout the course of the cultures. Variability in Mlc expression was a potential issue
encountered in the inducible arm of experiments; leaky regulation of the tac promoter
may have led to variable mlc transcription thereby affecting the levels of Mlc
overexpression.
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CHAPTER SEVEN: CONCLUSIONS
Leveraging the leaky regulation of the tac promoter, the inducible arm of this
work demonstrated constitutive expression of Mlc. When transformed in 1A2 cells and
grown overnight in City Broth, cultures expressing each of the eight mlc constructs grew
to higher density and better limited acetate accumulation compared to the wild-type
control. Variability was observed in the extent to how much each construct outperformed
the control based on levels of acetate and glucose measured across the duration of the
cultures. This trend may be the result of basing the overexpression of Mlc on the leaky
regulation of the tac promoter, however the exact reason for the variability could not be
determined.
Four of the mlc constructs were selected to be co-transformed with a plasmid
encoding for therapeutic protein A (TPA) in 16C9 cells. These were grown in overnight
shake flask cultures. Once again, each of the cultures overexpressing Mlc showed a
positive impact on limiting acetate accumulation and overall cell growth compared to the
control. However, as with the previous round of shake flask experiments, there was
variability in the extent to which the cultures overexpressing Mlc outperformed the
control. Ultimately, lower levels of acetate were observed in all test cases. RT-qPCR
data also showed an inverse relationship between the level of mlc RNA and acetate
accumulation. The GTG-R52H-His mlc construct was selected to be used the small scale
fermentation experiments.
When grown in the DASGIP bioreactors, cultures overexpressing Mlc
demonstrated a slower uptake of glucose resulting in minimal acetate accumulation over

73

the course of the experiment. These conditions allowed for the cultures to maintain a
greater optical density, which resulted in the greater production of TPA compared to the
control. Cultures overexpressing Mlc showed a 1.7-fold improvement in TPA production
compare to the control when normalized to the integrated optical density. Glucose
excursions were conducted in an attempt evaluate the how the cultures overexpressing
Mlc could handle a glucose overfeeding event. The excursions however, were not
significant enough (neither high enough feed rate or long enough in duration) to produce
a noticeable disturbance in the acetate or glucose profiles.
Analysis of the data from the eight mlc constructs evaluated in the pLMG17
(inducible) expression plasmid showed inconsistent relationships between the change in
the translational start codon (GTG to ATG) and point mutation at codon 52 (R52H) and
their effect on acetate accumulation in culture. This was likely the result of varying
levels of leaky transcription from the tac promoter. Though the data amongst the eight
mlc constructs was variable, each construct did outperform the wild-type control,
resulting in greater cell growth and lower acetate concentration in the media. Therefore,
the overexpression of Mlc via high-copy expression plasmid in E. coli does limit the
glucose uptake rate into the cell thereby limiting acetate accumulation and improving
overall cell growth. Additionally, the construct selected for growth in the small scale
fermentation, GTG-R52H-His, produced the most consistent and positive results
throughout the course of experimentation. This construct incorporated the point mutation
identified by Gerber et al. and suggests that the R52H mutation should be included in
future studies focusing on optimizing of Mlc overexpression.
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APPENDIX A
Table 12. A list of the materials to be used throughout the course of this study.
Restriction enzymes (New England Biolabs )
NcoI
HindIII
KpnI
XbaI
pBR322 based plasmid cloning vector (modified in-house at Genentech Inc.)
pACYC177 based plasmid cloning vector (modified in-house at Genentech Inc.)
Qiagen reagents
QIAquick Gel Extraction kit
QIAprep Miniprep kit
RNeasy Mini kit
Agarose gel running apparatus
Invitrogen E-Gel cassette holder
BioRad Mini Gel Sun GT
Agarose gels
Bio-Rad Mini ReadyAgarose TBE Gel (variable %)
Invitrogen E-Gel (variable %)
PCR (cloning) reagents
Taq DNA Polymerase & reaction buffer (Roche)
Mlc primers (Genentech Inc. in-house)
T4 DNA Ligase & reaction buffer (New England Biolabs)
QuikChange Site-Directed Mutagenesis kit (Stratagene)
QPCR reagents
TaqMan® One-Step RT-PCR Master Mix Reagents (Applied Biosystems)
Primers/probe (FAM/TAMRA) (Genentech Inc. in-house)
Bacterial cultures
Growth media: LB, City Broth, CRAP (Genentech Inc. in-house)
Antibiotic: chloramphenicol, kanamycin, tetracycline (Genentech Inc. in-house)
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APPENDIX B
pACYC177 primers
Insertion Primers
Forward (~25 bp upstream of kpnI site): 5’-CCGCTCATGAGACAATAACCCTGATA
AATGC
Reverse (~25 bp downstream of xbaI site): 5’-CATCTTATTAAGGGGTCTGACGCTC
AGTGGAACG
Start codon change
Forward (from GTG to ATG): 5’-GGCCGGTACCATGGTTGCTGAAAACCAGCCTG
GGC
Histidine Tag
Reverse: 5’-CCGGTCTAGATTAGTGATGGTGAGGTGATGACCCTGCAACAGACG
AATCAACAAAGAACCG
pLMG17 primers
Insertion Primers
Forward (~25 bp upstream of ncoI site):
5’-GGCTCGTATAATGTGTGGAATTGTGAGCGG
Reverse (~30 bp downstream of hindIII site):
5’-GCTTCTGCGTTCTGATTTAATCTGTATCAGGCTG
Start codon change
Forward (ncoI site plus change from GTG to ATG): 5’-GGCCCCATGGATGGTTGCT
GAAAACCAGCCTGGGC
Histidine Tag
Reverse: 5’-CCGGAAGCTTTTAGTGATGGTGATGGTGATGACCCTGCAACAGAC
GAATCAACAAAGAACCG
R52H Point Mutation
Forward: 5’-CTGCCAGTATCACTAAAATTGTCCATGAGATGCTCGAAGCACACC
TGGTGC
Reverse: 5’-GCACCAGGTGTGCTTCGAGCATCTCATGGACAATTTTAGTGATAC
TGGCAG
RT-qPCR Primers
Forward: 5’-TCCCGGTCATCTCAGACA
Reverse: 5’-CTGATGTGCTGACTATACG
Probe: 5’-ATCCGTCAGCAGGCCCTTCC
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APPENDIX C
Table 13. PCR protocol.
Step
Initial Melting
Denaturation
Annealing
Extension/Elongation
Final Elongation
Hold

Temperature (°C)
94
94
50
72
72
4
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Time
3 minutes
30 seconds
Repeated for
30 seconds
24 cycles
4 minutes
1 minute
∞

APPENDIX D
Ligation Protocol
Perform over ice
20 uL total volume
Combine the following:
Buffer: 2 uL
Vector: 1 uL
Insert: 2 uL
Ligase: 1 uL
Water: 14 uL
Incubate at 16oC overnight
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APPENDIX E
Transformations were carried out by heat shock. Approximately 100 µL of
competent cells of the desired host strain were thawed in 1.5 mL Eppendorf tubes over
ice. Next, 1 µL of the target plasmid was added and the mixture kept on ice for
approximately 30 minutes. The tube was then placed at 45°C for 90 seconds and then
placed back on ice for 60 seconds. 350 µL of super optimal broth with catabolite
repression (SOC) media was added and the tube incubated in a 37°C shaker for one hour.
The resulting culture was spread on LB plates with antibiotic added (antibiotic
determined based on resistance conveyed by targeted plasmid), and placed in a 37°C
incubator overnight.
One or two individual colonies were identified and re-streaked on antibiotic
containing LB plates and allowed to grow overnight in a 37°C incubator. Individual
colonies were be used to inoculate 5 mL cultures for either shake flask cultures or to
make vial lots in which the cells were frozen down for later use.
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APPENDIX F
Table 14. Raw growth, acetate, and growth data from single transformation of plMG17
(containing mlc insert) in 1A2.
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Table 15. Raw growth, acetate, and glucose data from double transformation of pLMG17
(containing mlc insert) and pTPA in 16C9.
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Table 16. Raw growth, acetate, glucose, and RT-qPCR data from DASGIP bioreactor
cultures.
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APPENDIX G

Figure 37. Total glucose fed over the initial five hours of small scale fermentation. Note
the increase in glucose fed to JB024 (overfeeding event as a result of glucose feeding
algorithm). Data from JB017 was excluded due to inaccurate measurement.

Figure 38. Total glucose fed over the initial 10 hours of small scale fermentation. Note
the significant increase in glucose fed to control cultures (JB023 and JB025) after six
hours. Data from JB017 was excluded due to inaccurate measurement.
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